Reset
Showing 4 of 84 academic articles

Artificial Intelligence for Clinical Trial Design

Stefan Harrer, Pratik P. Shah, Bhavna Josephine Antony, Jianying Hu • Trends in Pharmacological Sciences (2019)

Clinical trials consume the latter half of the 10 to 15 year, 1.5-2.0 billion USD, development cycle for bringing a single new drug to market. Hence, a failed trial sinks not only the investment into the trial itself but also the preclinica...

OPENALEX cc-by-nc-nd DOI: https://doi.org/10.1016/j.tips.2019.05.005

Artificial intelligence assisted 3D in the robotic urooncology? A systematic review and narrative synthesis of current applications, challenges and future directions

Bara Barakat, Bilal Al-Absi, Boris Hadaschik, Christian Rehme et al. • The Canadian Journal of Urology (2026)

Background: Artificial intelligence (AI)-assisted three-dimensional (3D) surgical platforms, integrated with augmented reality, have the potential to improve intraoperative anatomical recognition and provide surgeons with an immersive, dyna...

DOAJ Open Access (DOAJ) DOI: 10.32604/cju.2026.071284

Artificial intelligence in medicine

AN Ramesh, C. Kambhampati, J. Quinn Monson, Philip J. Drew • Annals of The Royal College of Surgeons of England (2004)

INTRODUCTION: Artificial intelligence is a branch of computer science capable of analysing complex medical data. Their potential to exploit meaningful relationship with in a data set can be used in the diagnosis, treatment and predicting ou...

OPENALEX Open Access DOI: https://doi.org/10.1308/147870804290 PMC: 1964229